Visit More ASCA Sites:
The Senate Health, Education, Labor and Pensions (HELP) Committee led by Chairman Tom Harkin (D-IA) and Ranking Member Mike Enzi (R-WY) introduced the US Food and Drug Administration’s (FDA) Prescription Drug User Fee Reauthorization Act, which includes a section on preventing and mitigating drug shortages (click here to access the legislation. The drug shortages provision would require manufacturers to notify the FDA at least 6 months in advance of discounting or interrupting the manufacturing of a drug. The provision also requires distribution of information to stakeholders in the physician community so they can plan and adjust care accordingly. #LegislationorRegulation
The Atrium Building277 S Washington St.Ste 375Alexandria, VA 22314
703.836.8808
asc@ascassociation.org
Medicare Resources
ASC Operations
Education & Events
Membership
About ASCs
News & Publications
Code of Conduct
Privacy Policy
Terms of Use
About ASCA
Join/Renew
Find an ASC
Get Involved
Marketing Opportunities
Contact Us